| HOME >> BIOLOGY >> TECHNOLOGY |
-------------------------------------------------------------------------
INVESTING
ACTIVITIES
Intellectual
property (586,124) (552,319) (99,066) (187,283) (6,085,404)
Property and
equipment (49,691) (29,342) (11,386) (8,294) (673,039)
Purchase of
short-term
investments (742,853) (801,358) (255,688) (261,480) (48,862,320)
Redemption of
short-term
investments - 10,158,000 - - 23,578,746
Investment
in BCY
LifeSciences
Inc. - - - - 464,602
Investment in
Transition
Therapeutics
Inc. - - - - 2,532,343
-------------------------------------------------------------------------
(1,378,668) 8,774,981 (366,140) (457,057) (29,045,072)
-------------------------------------------------------------------------
FINANCING
ACTIVITIES
Proceeds from
exercise of
warrants
and stock
options - 127,500 - 85,000 15,208,468
Proceeds from
private
placements - - - - 38,137,385
Proceeds from
public
offerings 12,063,394 - - - 42,856,898
-------------------------------------------------------------------------
12,063,394 127,500 - 85,000 96,202,751
-------------------------------------------------------------------------
Increase
(decrease)
in cash
and cash
equivalents
during
the period (165,137) 445,729 (3,597,515) (3,267,221) 3,326,374
Cash and
cash
equivalents,
'/>"/>
| SOURCE Oncolytics Biotech Inc. Copyright©2007 PR Newswire. All rights reserved |